HCA Healthcare (NYSE:HCA) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

HCA Healthcare (NYSE:HCA) had its price target hoisted by stock analysts at Royal Bank Of Canada from $482.00 to $525.00 in a research report issued on Friday,MarketScreener reports. The firm currently has an “outperform” rating on the stock. Royal Bank Of Canada’s price objective would indicate a potential upside of 12.63% from the stock’s current price.

A number of other equities analysts have also recently issued reports on the company. Wall Street Zen upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 25th. Weiss Ratings restated a “buy (b)” rating on shares of HCA Healthcare in a report on Monday. Stephens increased their target price on HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a research report on Monday, October 27th. Barclays raised their price objective on HCA Healthcare from $445.00 to $494.00 and gave the company an “overweight” rating in a report on Monday, October 27th. Finally, Cowen reiterated a “buy” rating on shares of HCA Healthcare in a report on Monday, October 27th. Fourteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $479.00.

HCA Healthcare Stock Down 1.2%

Shares of NYSE:HCA opened at $466.13 on Friday. The firm has a fifty day simple moving average of $468.96 and a two-hundred day simple moving average of $416.17. The stock has a market capitalization of $106.37 billion, a P/E ratio of 18.04, a PEG ratio of 1.39 and a beta of 1.36. HCA Healthcare has a 52 week low of $289.98 and a 52 week high of $520.00.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The business had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the business posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, analysts expect that HCA Healthcare will post 24.98 earnings per share for the current year.

Insider Buying and Selling

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 1.30% of the company’s stock.

Institutional Trading of HCA Healthcare

Large investors have recently bought and sold shares of the company. AIA Group Ltd acquired a new position in shares of HCA Healthcare during the 3rd quarter worth approximately $261,000. Mirabella Financial Services LLP grew its stake in shares of HCA Healthcare by 112.2% during the 3rd quarter. Mirabella Financial Services LLP now owns 12,715 shares of the company’s stock valued at $5,408,000 after buying an additional 6,724 shares during the period. Hudson Bay Capital Management LP lifted its stake in shares of HCA Healthcare by 154.5% during the third quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock worth $2,000,000 after purchasing an additional 2,849 shares in the last quarter. Allworth Financial LP raised its stake in shares of HCA Healthcare by 20.8% in the 3rd quarter. Allworth Financial LP now owns 1,174 shares of the company’s stock valued at $500,000 after purchasing an additional 202 shares in the last quarter. Finally, IFP Advisors Inc boosted its holdings in shares of HCA Healthcare by 5.5% in the 3rd quarter. IFP Advisors Inc now owns 8,277 shares of the company’s stock valued at $3,528,000 after buying an additional 434 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.